Side-by-side comparison of AI visibility scores, market position, and capabilities
AI drug information platform with clinical pharmacist review for healthcare providers; $6.5M seed from 645 Ventures and YC competing with UpToDate for complex drug interaction and dosing guidance.
InpharmD is an Atlanta-based healthcare technology company providing AI-assisted drug information and clinical pharmacist intelligence to healthcare providers — enabling physicians, nurses, and clinical staff to get evidence-based answers to complex drug questions (drug interactions, off-label use guidance, dosing in special populations, emerging therapies) through an AI platform that combines clinical pharmacist review with database-backed pharmaceutical intelligence. Founded in 2018 and a Y Combinator W21 graduate, InpharmD raised $6.63 million total including a $6.5 million seed round in December 2023 led by 645 Ventures with participation from Qlarant Capital and Atlanta Ventures.
Value-positioned RTD iced tea from PepsiCo-Unilever joint venture; bold flavors at accessible prices in convenience stores competing with AriZona in mainstream tea.
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positioned itself as a bold, value-priced iced tea targeting younger consumers who wanted flavorful, refreshing beverages at affordable prices — often sold in large cans and bottles that delivered more volume at lower per-ounce costs than premium tea brands. The brand's irreverent advertising featuring clay-animated celebrities became culturally memorable.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.